Published in

Endocrinology, Diabetes & Metabolism, 1(1), p. e00005

DOI: 10.1002/edm2.5

Links

Tools

Export citation

Search in Google Scholar

Preferential prescribing and utilization trends of diabetes medications among patients with renal impairment: Emerging role of linagliptin and other dipeptidyl peptidase 4 inhibitors

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO
Beta version